---
figid: PMC10965438__gr13
figtitle: Nanomaterials modulating TAMs polarization for the treatment of pancreatic
  cancer
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC10965438
filename: gr13.jpg
figlink: /pmc/articles/PMC10965438/figure/F13
number: F13
caption: 'Nanomaterials modulating TAMs polarization for the treatment of pancreatic
  cancer.(A) The NF-κB and HIF-1αsignaling pathway. (1) TAMs phagocytose nab-paclitaxel.
  Nab-paclitaxel promotes TLR4, activates the NF-κB signaling pathway, and induces
  M2-type TAM polarization to M1-type. (2) ppp dsRNA LCP-AEAA NPs knock out Bcl2 in
  pancreatic cancer cells and induce apoptosis. In addition, ppp dsRNA activates RIG-I,
  induces M2-type TAM polarization to M1-type, and releases TNF-α. The NF-κB signaling
  pathway may be involved. (3) Oxygen microcapsules release the oxygen, which inhibit
  the HIF-1αsignaling pathway and the polarization of M2 type TAM.(B) The PI3K/AKT
  signaling pathway. (1) GD@PP/Wtmn decomposed into GD and PP/Wtmn via CTSB in the
  pancreatic tumor tissue. GD induces apoptosis in pancreatic cancer cells. Wtmn in
  PP/Wtmn mice inhibited PI3K and subsequently AKT in M2-type TAMs, impairing TAM
  polarization to M2-type TAMs. (2) M2pep-MM/BEZ/siRNA targets M2-type TAMs to release
  BEZ 235 and CSF-1RsiRNA. BEZ 235 inhibited the PI3K/AKT signaling pathway in M2-type
  TAMs and weakened M2-type TAM polarization. CSF–1R knockdown using CSF–1R siRNA
  attenuates M2-type TAM polarization.(C) MicroRNAs: miR-155 and miR-125b. (1) HA-PEI/HA-PEG
  nanoparticles-encapsulated miR-155 and miR-125b were phagocytosed by pancreatic
  cancer cells to produce exosomes containing miR-155 and miR-125b. After being engulfed
  by M2-type TAMs, they promote M2-type TAM polarization to M1-type. (2) The HA-PEl/PEG-M2
  peptide miR-125b targets M2 type TAMs through M2pep, and miR-125b promotes M2-type
  TAM repolarization to M1-type.(D) CB-2. siMGLL/siCB-2 high GSH concentration in
  the cytoplasm promoted the release of siMGLL and siCB-2. siMGLL inhibited MGLL expression
  in pancreatic cancer cells, thereby inhibiting FFAs. siCB-2 inhibits CB-2 expression
  in M2-type TAMs, thereby promoting M2-type TAM polarization to M1-type and inhibits
  pancreatic cancer cells. TAMs, Tumor-associated macrophages; NF-kB, Nuclear factor-kappaB;
  HIF-1α, Hypoxia-inducible factor-1α; Nab-paclitaxel, Nanoparticle albumin-bound
  paclitaxel; TLR4, Toll-like receptor 4; ppp dsRNA LCP-AEAA NPs, 5′ triphosphate
  double-stranded RNA Lipid calcium phosphate-targeted with aminoethyl anisamide nanoparticles;
  Bcl2, B-cell lymphoma 2; ppp dsRNA, 5′ triphosphate double-stranded RNA; RIG-I,
  Retinoic acid-inducible gene I; TNF-α, Tumor necrosis factor-α; PI3K, Phosphatidylinositol-3hydroxykinase;
  AKT, AGC serine/threonine kinases; GD@PP/Wtmn, GEM conjugated dendritic poly-lysine
  DGL encapsulated to polycaprolactone-polyethylene glycol micelles loaded with wortmannin;
  CTSB, Cathepsin B; GD, GEM conjugated dendritic poly-lysine DGL; PP/Wtmn, polycaprolactone-polyethylene
  glycol micelles loaded with wortmannin; Wtmn, Wortmannin; M2pep-MM/BEZ/siRNA, M2
  macrophage-binding peptide- Mixed micelle/BEZ 235/short interfering RNA; HA-PEI/HA-PEG
  NP-Encapsulated miR-155 and miR-125b, Hyaluronic acid-poly (ethylene imine)/hyaluronic
  acid-poly (ethylene glycol) Nanoparticles-Encapsulated miR-155 and miR-125b; M2pep,
  M2 macrophage-binding peptide; CSF-1RsiRNA, Colony stimulating factor-1 receptor
  siRNA; CSF–1R, Colony stimulating factor-1 receptor; HAPEI/PEG-M2peptide miR-125b
  NPs, Hyaluronic acid-poly (ethylene imine)/hyaluronic acid-poly (ethylene glycol)-
  M2peptide miR-125b Nanoparticles; CB-2, Endocannabinoid receptor-2; NPs(siMGLL/siCB-2),
  NPs for co-delivery of MGLL siRNA and CB-2 siRNA; GSH, Glutathione; FFAs, Free fatty
  acids'
papertitle: Nanomaterials modulate tumor-associated macrophages for the treatment
  of digestive system tumors☆
reftext: Hao Li, et al. Bioact Mater. 2024 Jun;36(NA).
year: '2024'
doi: 10.1016/j.bioactmat.2024.03.003
journal_title: Bioactive Materials
journal_nlm_ta: Bioact Mater
publisher_name: KeAi Publishing
keywords: Digestive system tumors | Tumor-associated macrophages | Nanomaterials |
  Tumor immune microenvironment | Therapy
automl_pathway: 0.9556465
figid_alias: PMC10965438__F13
figtype: Figure
redirect_from: /figures/PMC10965438__F13
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC10965438__gr13.html
  '@type': Dataset
  description: 'Nanomaterials modulating TAMs polarization for the treatment of pancreatic
    cancer.(A) The NF-κB and HIF-1αsignaling pathway. (1) TAMs phagocytose nab-paclitaxel.
    Nab-paclitaxel promotes TLR4, activates the NF-κB signaling pathway, and induces
    M2-type TAM polarization to M1-type. (2) ppp dsRNA LCP-AEAA NPs knock out Bcl2
    in pancreatic cancer cells and induce apoptosis. In addition, ppp dsRNA activates
    RIG-I, induces M2-type TAM polarization to M1-type, and releases TNF-α. The NF-κB
    signaling pathway may be involved. (3) Oxygen microcapsules release the oxygen,
    which inhibit the HIF-1αsignaling pathway and the polarization of M2 type TAM.(B)
    The PI3K/AKT signaling pathway. (1) GD@PP/Wtmn decomposed into GD and PP/Wtmn
    via CTSB in the pancreatic tumor tissue. GD induces apoptosis in pancreatic cancer
    cells. Wtmn in PP/Wtmn mice inhibited PI3K and subsequently AKT in M2-type TAMs,
    impairing TAM polarization to M2-type TAMs. (2) M2pep-MM/BEZ/siRNA targets M2-type
    TAMs to release BEZ 235 and CSF-1RsiRNA. BEZ 235 inhibited the PI3K/AKT signaling
    pathway in M2-type TAMs and weakened M2-type TAM polarization. CSF–1R knockdown
    using CSF–1R siRNA attenuates M2-type TAM polarization.(C) MicroRNAs: miR-155
    and miR-125b. (1) HA-PEI/HA-PEG nanoparticles-encapsulated miR-155 and miR-125b
    were phagocytosed by pancreatic cancer cells to produce exosomes containing miR-155
    and miR-125b. After being engulfed by M2-type TAMs, they promote M2-type TAM polarization
    to M1-type. (2) The HA-PEl/PEG-M2 peptide miR-125b targets M2 type TAMs through
    M2pep, and miR-125b promotes M2-type TAM repolarization to M1-type.(D) CB-2. siMGLL/siCB-2
    high GSH concentration in the cytoplasm promoted the release of siMGLL and siCB-2.
    siMGLL inhibited MGLL expression in pancreatic cancer cells, thereby inhibiting
    FFAs. siCB-2 inhibits CB-2 expression in M2-type TAMs, thereby promoting M2-type
    TAM polarization to M1-type and inhibits pancreatic cancer cells. TAMs, Tumor-associated
    macrophages; NF-kB, Nuclear factor-kappaB; HIF-1α, Hypoxia-inducible factor-1α;
    Nab-paclitaxel, Nanoparticle albumin-bound paclitaxel; TLR4, Toll-like receptor
    4; ppp dsRNA LCP-AEAA NPs, 5′ triphosphate double-stranded RNA Lipid calcium phosphate-targeted
    with aminoethyl anisamide nanoparticles; Bcl2, B-cell lymphoma 2; ppp dsRNA, 5′
    triphosphate double-stranded RNA; RIG-I, Retinoic acid-inducible gene I; TNF-α,
    Tumor necrosis factor-α; PI3K, Phosphatidylinositol-3hydroxykinase; AKT, AGC serine/threonine
    kinases; GD@PP/Wtmn, GEM conjugated dendritic poly-lysine DGL encapsulated to
    polycaprolactone-polyethylene glycol micelles loaded with wortmannin; CTSB, Cathepsin
    B; GD, GEM conjugated dendritic poly-lysine DGL; PP/Wtmn, polycaprolactone-polyethylene
    glycol micelles loaded with wortmannin; Wtmn, Wortmannin; M2pep-MM/BEZ/siRNA,
    M2 macrophage-binding peptide- Mixed micelle/BEZ 235/short interfering RNA; HA-PEI/HA-PEG
    NP-Encapsulated miR-155 and miR-125b, Hyaluronic acid-poly (ethylene imine)/hyaluronic
    acid-poly (ethylene glycol) Nanoparticles-Encapsulated miR-155 and miR-125b; M2pep,
    M2 macrophage-binding peptide; CSF-1RsiRNA, Colony stimulating factor-1 receptor
    siRNA; CSF–1R, Colony stimulating factor-1 receptor; HAPEI/PEG-M2peptide miR-125b
    NPs, Hyaluronic acid-poly (ethylene imine)/hyaluronic acid-poly (ethylene glycol)-
    M2peptide miR-125b Nanoparticles; CB-2, Endocannabinoid receptor-2; NPs(siMGLL/siCB-2),
    NPs for co-delivery of MGLL siRNA and CB-2 siRNA; GSH, Glutathione; FFAs, Free
    fatty acids'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - BCL2
  - NPS
  - MIR155
  - CTSB
  - TLR4
  - NOS2
  - ISYNA1
  - NFKB1
  - MRC1
  - HIF1A
  - CD163
  - UQCRC2
  - RETNLB
  - CNR2
  - AKT1
  - AKT2
  - AKT3
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - CSF1R
  - TNF
  - PPI
  - GSH
  - BEZ 235
  - TNF-a
---
